Prognosis of Apical Hypertrophic Cardiomyopathy in Patients With Implantable Cardioverter Defibrillators

被引：0
|
作者：
Kondo, Yusuke
Nakano, Miyo
Nakano, Masahiro
Kajiyama, Takatsugu
Kobayashi, Yoshio
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Hypertrophic cardiomyopathy; Implantable cardioverter defibrillator (ICD);
D O I：
10.1161/circ.148.suppl_1.19218
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A19218
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry
    Gerrit Frommeyer
    Florian Reinke
    Dietrich Andresen
    Thomas Kleemann
    Stefan G. Spitzer
    Joachim Jehle
    Johannes Brachmann
    Christoph Stellbrink
    Matthias Hochadel
    Jochen Senges
    Lars Eckardt
    Clinical Research in Cardiology, 2020, 109 : 508 - 512
  • [42] Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry
    Frommeyer, Gerrit
    Reinke, Florian
    Andresen, Dietrich
    Kleemann, Thomas
    Spitzer, Stefan G.
    Jehle, Joachim
    Brachmann, Johannes
    Stellbrink, Christoph
    Hochadel, Matthias
    Senges, Jochen
    Eckardt, Lars
    CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (04) : 508 - 512
  • [43] Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?
    Gersh, Bernard
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2004, 1 (01): : 16 - 17
  • [44] Anxiety in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Implantable Cardioverter Defibrillators
    Day, Sharlene M.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2012, 5 (01) : 2 - 4
  • [45] Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?
    Bernard Gersh
    Nature Clinical Practice Cardiovascular Medicine, 2004, 1 : 16 - 17
  • [46] Characteristics of the phenotype of mixed cardiomyopathy in patients with implantable cardioverter-defibrillators
    Deep Chandh Raja
    Indira Samarawickrema
    Sarat Krishna Menon
    Rikvin Singh
    Abhinav Mehta
    Lukah Q. Tuan
    Ulhas Pandurangi
    Sanjiv Jain
    David J. Callans
    Francis E. Marchlinski
    Walter P. Abhayaratna
    Prashanthan Sanders
    Rajeev K. Pathak
    Journal of Interventional Cardiac Electrophysiology, 2024, 67 : 129 - 137
  • [47] Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy
    Daubert, James P.
    Barnett, Adam S.
    JACC-HEART FAILURE, 2019, 7 (08) : 725 - 727
  • [48] Characteristics of the phenotype of mixed cardiomyopathy in patients with implantable cardioverter-defibrillators
    Raja, Deep Chandh
    Samarawickrema, Indira
    Menon, Sarat Krishna
    Singh, Rikvin
    Mehta, Abhinav
    Tuan, Lukah Q. Q.
    Pandurangi, Ulhas
    Jain, Sanjiv
    Callans, David J. J.
    Marchlinski, Francis E. E.
    Abhayaratna, Walter P. P.
    Sanders, Prashanthan
    Pathak, Rajeev K. K.
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2024, 67 (01) : 129 - 137
  • [49] Cognitive deficits in ischemic cardiomyopathy patients with implantable cardioverter-defibrillators
    Bennett, SJ
    Sauve, MJ
    Kim, J
    Lowe, MR
    Foreman, LD
    Oldridge, NB
    Nair, GV
    Bhakta, D
    Groh, WJ
    CIRCULATION, 2005, 112 (17) : U761 - U761
  • [50] Implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy - A nationwide study
    Amin, A.
    Tsangaris, A.
    Arora, A.
    Satya, K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 54 - 55
12345